Movement Disorders Group Explores Impact, Treatment Barriers in New White Paper
Millions of people are affected by neurological conditions known as movement disorders: Parkinson’s disease, essential tremor, tardive dyskinesia and more.
Health Plan Approval Process Impacts Patients, New Video Explains
What began as a safeguard against unnecessary drug spending has become a significant barrier to patient access. And as “Understanding Prior Authorization,” a new video from the Alliance for Patient Access, explains, the process may cut costs at patients’ expense.
Mind-Body Pain Treatments Pass ICER’s Cost-Effectiveness Test
Treating chronic low back pain with approaches such as yoga and talk therapy is cost effective, the Institute for Clinical and Economic Review announced this month. Will health plans respond by expanding coverage for non-pharmacologic therapies?
The Mental Illness Problem Hidden in Plain Sight
Depression, bipolar disorder, ADHD, schizophrenia and obsessive compulsive disorder – mental illness takes multiple forms.
Diabetes Patients’ New Challenge: Non-Medical Switching
“Managing diabetes is an all-day, every-day task for millions of Americans,” explains a new video from the Diabetes Policy Collaborative.
Experts Move to Protect Women & Unborn Children from Hepatitis C
New treatment guidelines convey a startling reality: hepatitis C isn’t only a baby boomer problem anymore.
The Price and Value of Orphan Drugs
How do you put a price tag on a drug that offers life-altering results – but for a small group of patients? The question is becoming increasingly relevant with the rise of innovative, targeted medicine.
Drugs, Data & Opioid Policies
America’s drug abuse crisis has reached epic proportions, a recent report from the Centers for Disease Control and Prevention confirms. Drug-related deaths in 2016 alone spiked by 22 percent.
Why Patients with Skin Conditions Can’t Get Treated
Tens of millions of people across the United States are affected by skin conditions, but not all of them can access the doctors and medications they need. So explains a new white paper from the Derma Care Access Network, an advocacy group that encourages informed policy on access to dermatological care.
“Fast Facts” on Pharmacovigilance Tackles Drug Safety Issues
One in three U.S. drugs may have safety issues, explains a new Fast Facts policy brief from the Institute for Patient Access.
